West Chester, PA, United States of America

Sally Doreen P Lyn


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sally Doreen P Lyn

Introduction

Sally Doreen P Lyn is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of medical research, particularly in understanding tumor necrosis factor receptors. His work has implications for diagnosing and treating various diseases.

Latest Patents

Sally Doreen P Lyn holds 1 patent titled "Methods of determining the level of human tumor necrosis factor receptor-like 2." This invention relates to novel members of the Tumor Necrosis Factor family of receptors. It provides isolated nucleic acid molecules encoding a human TR2 receptor and two splice variants thereof. The invention also includes TR2 polypeptides, vectors, host cells, and recombinant methods for producing these components. Furthermore, it outlines screening methods for identifying agonists and antagonists of TR2 receptor activity. Diagnostic methods for detecting disease states related to the aberrant expression of TR2 receptors are also provided. Additionally, therapeutic methods for treating disease states related to aberrant proliferation and differentiation of cells expressing TR2 receptors are included.

Career Highlights

Throughout his career, Sally Doreen P Lyn has worked with prominent companies in the biotechnology sector. He has been associated with Human Genome Sciences, Inc. and SmithKline Beecham Corporation. His work in these organizations has contributed to advancements in genetic research and therapeutic development.

Collaborations

Sally Doreen P Lyn has collaborated with notable professionals in his field, including Jian Ni and Craig A Rosen. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Sally Doreen P Lyn's contributions to the field of medical research through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding and treating diseases related to tumor necrosis factor receptors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…